Aiyar N, Rand K, Elshourbagy N A, Zeng Z, Adamou J E, Bergsma D J, Li Y
Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
J Biol Chem. 1996 May 10;271(19):11325-9. doi: 10.1074/jbc.271.19.11325.
Calcitonin gene-related peptide (CGRP) is a neuropeptide with diverse biological effects including potent vasodilator activity. We report here the cloning of a complementary DNA (cDNA) encoding a human CGRP1 receptor, which shares significant peptide sequence homology with the human calcitonin receptor, a member of the G-protein-coupled receptor superfamily. Northern blot analysis revealed that the messenger RNA for this receptor is predominantly expressed in the lung and heart. In situ studies showed specific localization of the receptor mRNA to alveolar cells in the lung and to cardiac myocytes in the heart. Stable expression of the cDNA in human embryonic kidney 293 (HEK 293) cells produced specific, high affinity binding sites for CGRP that displayed pharmacological and functional properties very similar to native human CGRP1 receptor. Exposure of these cells to CGRP resulted in a 60-fold increase in cAMP production, which was inhibited in a competitive manner by the CGRP1 receptor antagonist, CGRP-(8-37).
降钙素基因相关肽(CGRP)是一种具有多种生物学效应的神经肽,包括强大的血管舒张活性。我们在此报告编码人CGRP1受体的互补DNA(cDNA)的克隆,该受体与G蛋白偶联受体超家族成员人降钙素受体具有显著的肽序列同源性。Northern印迹分析显示该受体的信使RNA主要在肺和心脏中表达。原位研究表明受体mRNA在肺中的肺泡细胞和心脏中的心肌细胞中特异性定位。cDNA在人胚肾293(HEK 293)细胞中的稳定表达产生了对CGRP的特异性、高亲和力结合位点,其显示出与天然人CGRP1受体非常相似的药理学和功能特性。将这些细胞暴露于CGRP导致cAMP产生增加60倍,这被CGRP1受体拮抗剂CGRP-(8-37)以竞争性方式抑制。